Investing Profile

William Szczepaniak

VCInvestorScout
Pre- and seed-stage investor in health and life science companies.
Photo of William Szczepaniak, Managing Director at UCeed Funds

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
UCeed Funds Managing Director
$50K - $300K
$150K
15
CompanyStageDateRound SizeTotal Raised
Zymedyne Therapeutics
Pre-SeedN/A
Trexo Robotics
SeedN/A
Tactile Orthopaedics
SeedN/A
Syantra
SeedN/A
$7M
Co-investors: Saeed Amidi (Plug & Play Ventures)
Reach Orthopaedics
Pre-SeedN/A
Qualisure Diagnostics
Pre-SeedN/A
PulseMedica
SeedN/A
Nimble Science
Pre-SeedN/A
$2M
Co-investors: Gregory Baker (Bascom Ventures)
Therapeutics, medical devices, diagnostics, digital health, biotechnology, scientific instruments.
Health and Wellness solutions that have no plan to collect clinical trial evidence of efficacy.